The global skin grafting device market size is estimated to be valued at USD 1,084.9 Million in 2025 and is projected to reach USD 1,519.0 Million by 2032, exhibiting a CAGR of 7.3% during the forecast period (2025–2032).
The skin grafting device market growth is primarily driven by the increasing incidence of burns, chronic wounds, and skin injuries, coupled with the rising demand for advanced wound care solutions. Moreover, the growing adoption of minimally invasive procedures, technological advancements in dermatology, and the expansion of healthcare infrastructure are further propelling the market growth.
However, high procedural costs, risk of infection, and limited availability of skilled professionals may restrain the overall market expansion.
Key Market Insights
The global skin grafting device market is witnessing consistent growth, driven by technological advancements in skin regeneration devices, increasing investments in healthcare infrastructure, and rising demand for customized grafting solutions. The surge in road accidents, surgical wounds, and chronic skin disorders such as venous leg ulcers and diabetic foot ulcers further boosts demand.
The full report is now available for purchase: https://www.coherentmi.com/industry-reports/global-skin-grafting-device-market
Skin Grafting Device Market Report Coverage
|
Report Coverage |
Details |
|
Market Revenue in 2025 |
USD 1,084.9 Million |
|
Estimated Value by 2032 |
USD 1,519.0 Million |
|
Growth Rate |
7.3% |
|
Historical Data |
2020–2024 |
|
Forecast Period |
2025–2032 |
|
Forecast Units |
Value (USD million) |
|
Report Coverage |
Revenue Forecast, Competitive Landscape, Growth Factors, and Trends |
|
Segments Covered |
|
|
Geographies Covered |
North America (U.S. and Canada), Latin America (Brazil, Argentina, Mexico, and Rest of Latin America), Europe (Italy, Spain, U.K., Germany, France, Russia, and Rest of Europe), Asia Pacific (China, India, Japan, Australia, South Korea, ASEAN, and Rest of Asia Pacific), Middle East (GCC Countries, Israel, and Rest of Middle East), and Africa (South Africa, North Africa, and Central Africa) |
|
Growth Drivers |
|
|
Opportunities |
|
|
Trends |
|
|
Restraints & Challenges |
|
Market Dynamics
The global skin grafting device market is undergoing a significant transformation, driven by continuous innovation in grafting materials, device integration, and regenerative wound care technologies. Increasing focus on biologically active and hybrid grafting solutions is reshaping clinical practices by improving graft adherence, reducing healing time, and enhancing patient outcomes.
In September 2025, AVITA Medical launched Cohealyx, a collagen-based dermal matrix co-developed with Regenity. Designed to promote cellular migration and re-vascularization, Cohealyx integrates into the wound bed within seven days, expanding AVITA’s product portfolio beyond its flagship RECELL System.
Similarly, in December 2024, Kerecis introduced SurgiClose Silicone, a fish-skin graft product with a silicone backing that enhances wound contact and simplifies application in surgical and trauma cases.
These advancements underscore the market’s transition toward next-generation grafting systems that merge biocompatible materials, smart delivery mechanisms, and minimally invasive designs—positioning the skin grafting device market for sustained growth and technological sophistication in the years ahead.
Market Trends
Automation in skin graft manufacturing is becoming a major trend as companies focus on scalability and precision in regenerative medicine.
In August 2024, Cutiss AG advanced its denovoCast platform—an automated system for producing large, patient-specific dermo-epidermal skin grafts (denovoSkin)—from R&D to industrialization, supported by the Swiss Innovation Agency (Innosuisse). This innovation enables high-throughput, reproducible production of personalized grafts, reducing manual intervention and operational costs.
The integration of 3D bioprinting technology into skin grafting is reshaping the clinical approach to wound repair.
In May 2025, Inventia Life Science initiated a world-first clinical trial in Australia using its LIGŌ device—a handheld bioprinter capable of depositing patient-derived “bio-ink” directly into wound sites with real-time imaging guidance. This enables precise, on-site fabrication of skin layers that conform to complex wound geometries, minimizing donor-site harvesting and improving healing outcomes
Market Opportunities
Global collaboration initiatives in regenerative medicine are creating significant growth opportunities for innovation in skin grafting devices. Multinational research consortia such as EU Horizon Europe, NIH (U.S.), and Japan’s AMED are funding cross-border projects that merge biotechnology with device engineering to accelerate clinical translation.
Collaborations between device manufacturers and research laboratories are accelerating the development of next-generation bioengineered skin substitutes integrating stem cells, collagen scaffolds, and growth factors. These hybrid grafts aim to improve vascularization, graft take, and wound healing efficiency.
In October 2023, researchers led by Correa-Araujo et al. published a study in Stem Cell Research & Therapy (BioMed Central) demonstrating the successful creation of bioengineered skin constructs combining mesenchymal stromal cells (MSCs) with acellular dermal matrices. This hybrid design enhanced growth factor release and tissue regeneration in wound repair models, underscoring significant progress in the development of next-generation tissue-engineered skin substitutes.
Analyst View
Key Developments
Competitive Landscape
Global Skin Grafting Device Market Segmentation
Regional Insights
Related Reports :